REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 21st, 2020 • GBS Inc. • Surgical & medical instruments & apparatus
Contract Type FiledDecember 21st, 2020 Company IndustryThis Agreement is made pursuant to the Exchange Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Exchange Agreement”).
COMMON STOCK PURCHASE WARRANT GBS INC.Security Agreement • December 21st, 2020 • GBS Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 21st, 2020 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Life Science Biosensor Diagnostics Pty Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December [_], 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from GBS Inc., a Delaware corporation (the “Company”), up to 3,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXCHANGE AGREEMENTExchange Agreement • December 21st, 2020 • GBS Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 21st, 2020 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (this “Agreement”) is entered into as of December [_], 2020, by and between GBS, Inc., a Delaware corporation (the “Company”), Life Science Biosensor Diagnostics Pty Ltd (“LSBD” or the “Holder”), each a “Party” and collectively the “Parties”, upon the following premises:
PURCHASE AND ASSIGNMENT AGREEMENTPurchase and Assignment Agreement • December 21st, 2020 • GBS Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 21st, 2020 Company Industry JurisdictionTHIS PURCHASE AND ASSIGNMENT AGREEMENT (this “Agreement”) is entered into on December 18, 2020, by and between Life Science Biosensor Diagnostics Pty Ltd., an Australian proprietary limited company having an address at Level 7, 222 Clarence Street, Sydney NSW 2000 Australia (the “Seller”) and the undersigned investor (the “Purchaser”).